Plavix (clopidogrel) is an Expensive Failure for Treating Patients with Strokes

A major study treating patients who had suffered a stroke with Plavix added to aspirin was halted early because of safety and futility. One aspirin a day did just as well in preventing a second stroke as aspirin plus Plavix, and there were twice as many major hemorrhages when Plavix was added. Plavix is commonly used in the cardiovascular community with little respect for its high cost and risk of side effects. Perhaps this study will help lesson its unwarranted use. See Stroke(click here) 2011;42:227-76.